KD Logo

GMED’s latest rating updates from top analysts.

In a filing, Globus Medical Inc revealed its Director Lemaitre Dan unloaded Company’s shares for reported $4.09 million on May 10 ’24. In the deal valued at $64.61 per share,63,300 shares were sold. As a result of this transaction, Lemaitre Dan now holds 0 shares worth roughly $0.0.

Then, Davidar David D sold 20,000 shares, generating $1,300,000 in total proceeds. Upon selling the shares at $65.00, the Director now owns 566,275 shares.

Before that, Norwalk Leslie V sold 10,590 shares. Globus Medical Inc shares valued at $550,574 were divested by the Director at a price of $51.99 per share. As a result of the transaction, Norwalk Leslie V now holds 17,419 shares, worth roughly $1.09 million.

BTIG Research upgraded its Globus Medical Inc [GMED] rating to a Buy from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including ROTH MKM’s analysts, who began to cover the stock in mid October with a ‘”a Buy”‘ rating. Stifel also remained covering GMED and has increased its forecast on September 19, 2023 with a “Buy” recommendation from previously “Hold” rating. Canaccord Genuity revised its rating on March 30, 2023. It rated GMED as “a Buy” which previously was an “a Hold”.

Price Performance Review of GMED

On Tuesday, Globus Medical Inc [NYSE:GMED] saw its stock fall -1.43% to $62.84. Over the last five days, the stock has gained 22.35%. Globus Medical Inc shares have risen nearly 17.92% since the year began. Nevertheless, the stocks have risen 10.58% over the past one year. While a 52-week high of $65.74 was reached on 05/08/24, a 52-week low of $43.38 was recorded on 05/01/24. SMA at 50 days reached $53.27, while 200 days put it at $52.14. A total of 0.74 million shares were traded, compared to the trading of 1.22 million shares in the previous session.

Levels Of Support And Resistance For GMED Stock

The 24-hour chart illustrates a support level at 61.80, which if violated will result in even more drops to 60.76. On the upside, there is a resistance level at 64.21. A further resistance level may holdings at 65.58. The Relative Strength Index (RSI) on the 14-day chart is 72.22, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 8.54, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 17.67%. Stochastics %K at 88.00% indicates the stock is a selling.

Most Popular

[the_ad id="945"]